FARMERS & MERCHANTS INVESTMENTS INC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1259969
LINCOLN, NE
Position in PTGX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,290
+$601 QoQ
Shares Held
35
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#312
of 341 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FARMERS & MERCHANTS INVESTMENTS INC holds $751,654 across 32 Biotechnology names. PTGX ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
12,625 | $492,501 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
170 | $84,444 | |
| 3 | ELDN |
Eledon Pharmaceuticals, Inc.
|
6,321 | $24,904 | |
| 4 | INCY |
Incyte Corp
|
164 | $18,591 | |
| 5 | MRNA |
Moderna, Inc.
|
210 | $14,706 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
54 | $13,012 | |
| 7 | EXEL |
Exelixis, Inc.
|
235 | $12,786 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
330 | $11,678 |
All Filings in PTGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,290 | 35 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,689 | 35 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,056 | 35 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,325 | 35 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,934 | 35 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,692 | 35 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,351 | 35 | Shares | Sole | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||